marijuana stocks news

Vertical Designs Terminates Abbatis Licence

VANCOUVER, Dec. 30, 2014 /CNW/ – Vertical Designs Ltd. (“Vertical Designs”, “VDL” or the “Company”) announced today that they have issued notice of termination of the License Agreement dated December 12, 2012 with Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT), on the grounds of material breach of the Licence Agreement by Abbatis.  The termination of the License Agreement is effective immediately.

Abbatis has been instructed that all Confidential materials (as that term is defined in the License Agreement) must be returned to VDL offices.

About Vertical Designs Inc.

Vertical Designs Ltd. of Vancouver, B.C. is a privately owned company that designs and builds innovative, fully sustainable and complete vertical growing solutions. VDL is capable of producing local, truly nutritious, safe, secure, environmentally friendly and low (total) cost food crops year-round. Its proprietary technologies control precise combinations of light, temperature, water, and nutrients to create specific growing conditions that result in optimum crop production, product quality and shelf- life. Vertical Designs systems can be used to produce leafy greens vegetables like lettuce, spinach and herbs as well as plants that require pollination such as strawberries.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Verano Holdings Corp. (VRNOF) Refinances $350 Million Credit Facility

Verano Refinances $350 Million Credit Facility with Significant Optionality to Bolster Strategic…

Cronos Group Inc. (CRON) to Hold 2022 Second Quarter Earnings Conference Call on August 9, 2022

Cronos Group Inc. to Hold 2022 Second Quarter Earnings Conference Call on…

Cannabis Science, Inc. (CBIS) Appoints Dr. Joe Wilson, an Information Technology and Risk Management

Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk…

$GWPH Deadline in a Newly Filed Class Action

Hagens Berman Reminds GW Pharmaceuticals (NASDAQGM:GWPH) Investors of March 21, 2016 Lead…